Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Menarini Silicon Biosystems launches CELLSEARCH® Circulating Multiple Myeloma Cells Assay, a new non-invasive test to monitor disease status in clinical research studies 2021-03-31 10:00
Viva Biotech Announced 2020 Annual Results 2021-03-31 07:03
European Commission Approves mAbxience's Bevacizumab For The Treatment Of Certain Types Of Cancer 2021-03-31 05:30
Ajinomoto Bio-Pharma Services Expands Manufacturing Agreement with AstraZeneca to Include Drug Product Manufacturing 2021-03-31 01:04
GemVax's highly promising Phase II Alzheimer's disease clinical trial results targeting telomerase published in prestigious Alzheimer's Research & Therapy' journal 2021-03-30 19:21
Ascletis Announces Investment Escalation in R&D of Cancer Lipid Metabolism and Oral Checkpoint Inhibitors 2021-03-30 08:00
Novel Phenomics NASH In Vitro Assay Presented by InSphero AG and PharmaNest Inc at 2021 Society of Toxicology Meeting 2021-03-30 05:20
Amplicore, Inc. Announces Closing of a Successful $4M Seed Funding Round 2021-03-30 02:55
Kazia Licenses Rights to Paxalisib in Greater China to Simcere, a Leading Chinese Pharmaceutical Company 2021-03-29 17:43
Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust for the Company's COVID-19 Vaccine Candidate 2021-03-29 16:07
Henlius Plans to File the NDA of Novel anti-PD-1 mAb HLX10 for the Treatment of MSI-H Solid Tumours, the Phase 2 Clinical Trial has Met the Primary Endpoint 2021-03-29 08:27
Making Most out of Launched Products Fueling Diversified Innovation through Integrated Platform 2021-03-28 11:16
Genscript Biotech Reports Full Year 2020 Financial Results 2021-03-27 02:16
Modern Chinese Medicine Announces Year 2020 Annual Results 2021-03-26 22:08
Saxenda® recommended for approval by European Medicines Agency committee for the treatment of obesity in adolescents aged 12-17 years 2021-03-26 21:31
Airway Therapeutics Announces FDA Acceptance of IND for AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD) 2021-03-26 16:00
Ascentage Pharma Announces Publication of Preclinical Data in Nature Immunology Showing Enhanced T-Cell-Mediated Antitumor Immunity Induced by Its MDM2-p53 Inhibitor APG-115 2021-03-26 08:38
Antengene Announces Financial Results for Full Year 2020 2021-03-26 08:00
Chime Biologics Announced the Completion of US$190 Million Series A+ Financing to Accelerate Capacity Expansion 2021-03-26 08:00
Amplicore, Inc. Announces Closing of a Successful $4M Seed Funding Round 2021-03-26 05:19
1 130 131 132 133 134 235